Singular Genomics Systems Inc (OMIC)
0.4032
+0.01
(+2.60%)
USD |
NASDAQ |
May 21, 15:42
Singular Genomics Systems Gross Profit Margin (Quarterly): -94.80% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -94.80% |
December 31, 2023 | -42.28% |
September 30, 2023 | -14.07% |
Date | Value |
---|---|
June 30, 2023 | -18.22% |
March 31, 2023 | 6.49% |
December 31, 2022 | -3.14% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-94.80%
Minimum
Mar 2024
6.49%
Maximum
Mar 2023
-27.67%
Average
-16.14%
Median
Gross Profit Margin (Quarterly) Benchmarks
Azenta Inc | 39.83% |
Harvard Bioscience Inc | 60.26% |
Standard BioTools Inc | 53.11% |
Bionano Genomics Inc | 32.20% |
Akoya Biosciences Inc | 45.66% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -48.42% |
Return on Assets | -34.90% |
Return on Invested Capital | -46.24% |
Profit Margin (Quarterly) | -5.66K% |
Operating Margin (Quarterly) | -6.07K% |
Return on Net Operating Assets | -104.2% |